Isolated Diastolic Hypertension Management

Diagnosis and Treatment

The European Society of Cardiology recommends verifying elevated blood pressure with out-of-office measurements to confirm sustained hypertension ≥140/90 mmHg 1
The European Society of Cardiology suggests assessing for secondary causes if the patient is young (<40 years), has resistant hypertension, or has suggestive clinical features 1
The European Society of Cardiology recommends starting both lifestyle modifications and pharmacological treatment simultaneously for confirmed hypertension (BP ≥140/90 mmHg) 1
First-line pharmacological agents for isolated diastolic hypertension include ACE inhibitors, ARBs, dihydropyridine calcium channel blockers, or thiazide diuretics, as recommended by the European Society of Cardiology 1
The European Society of Cardiology recommends a preferred initial approach of starting with monotherapy in IDH, reserving combination therapy for inadequate response 1, 2

The European Society of Cardiology recommends sodium restriction (<2 g/day) as part of lifestyle modifications for isolated diastolic hypertension 1
The European Society of Cardiology suggests weight loss if overweight (BMI >25 kg/m²) as part of lifestyle modifications for isolated diastolic hypertension 3
The European Society of Cardiology recommends regular aerobic exercise (150 minutes/week) as part of lifestyle modifications for isolated diastolic hypertension 3
The European Society of Cardiology suggests limiting alcohol consumption as part of lifestyle modifications for isolated diastolic hypertension 3
The European Society of Cardiology recommends a DASH diet pattern as part of lifestyle modifications for isolated diastolic hypertension 1, 2

The European Society of Cardiology recommends a goal blood pressure of <140/90 mmHg for most patients with isolated diastolic hypertension 1, 2
The European Society of Cardiology suggests monitoring blood pressure every 2-4 weeks during titration and every 3-6 months once controlled 1
The European Society of Cardiology recommends assessing for orthostatic hypotension at each visit and monitoring for symptoms of hypoperfusion 3, 4
The European Society of Cardiology suggests screening for target organ damage, including checking renal function, urinalysis for proteinuria, and ECG for left ventricular hypertrophy 2